Development and validation of a deep learning algorithm for improving Gleason scoring of prostate cancer K Nagpal et al, NPJ Digital Medicine, June 7, 2019

Main|Search|PHGKB




Last Posted: Jun 07, 2019

---

• Development and validation of a deep learning algorithm for improving Gleason scoring of prostate cancer
  K Nagpal et al, NPJ Digital Medicine, June 7, 2019
• Genetic polymorphism and carbonic anhydrase 9 expression can predict nodal metastatic prostate cancer risk in patients with prostate-specific antigen levels ≤10 ng/ml at initial biopsy.
  Lin Chia-Yen et al. Urologic oncology 2019 May
• Clinical implications of genetic aberrations in metastatic prostate cancer.
  Reichert Zachery R et al. Current opinion in urology 2019 Jul 29(4) 319-325
• NCCN Guidelines Updates: Management of Prostate Cancer.
  Mohler James L et al. Journal of the National Comprehensive Cancer Network : JNCCN 2019 May 17(5.5) 583-586
• User-testing an interactive option grid decision aid for prostate cancer screening: lessons to improve usability.
  Scalia Peter et al. BMJ open 2019 May 9(5) e026748
• Does a family history of prostate cancer affect screening behavior in Jamaican men?
  Morrison Belinda F et al. Revista panamericana de salud publica = Pan American journal of public health 2018 42e143
• The Role of BRCA Testing in Hereditary Pancreatic and Prostate Cancer Families.
  Pilarski Robert et al. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 2019 Jan 3979-86
• Racial Inequality in Prostate Cancer Outcomes—Socioeconomics, Not Biology
  CJ Paller et al, JAMA Oncology, May 23, 2019
• African American Specific Gene Panel Predictive of Poor Prostate Cancer Outcome.
  Echevarria Michelle I et al. The Journal of urology 2019 Feb 101097JU0000000000000193
• Germline and Somatic Mutations in Prostate Cancer for the Clinician.
  Cheng Heather H et al. Journal of the National Comprehensive Cancer Network : JNCCN 2019 May 17(5) 515-521

more